Erythropoietin (EPO) Drugs Market - Global Outlook and Forecast 2023-2028

Report ID: 1365589 | Published Date: Oct 2024 | No. of Page: 63 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Erythropoietin (EPO) Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Erythropoietin (EPO) Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Erythropoietin (EPO) Drugs Overall Market Size
    2.1 Global Erythropoietin (EPO) Drugs Market Size: 2021 VS 2028
    2.2 Global Erythropoietin (EPO) Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Erythropoietin (EPO) Drugs Players in Global Market
    3.2 Top Global Erythropoietin (EPO) Drugs Companies Ranked by Revenue
    3.3 Global Erythropoietin (EPO) Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Erythropoietin (EPO) Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Erythropoietin (EPO) Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Erythropoietin (EPO) Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Erythropoietin (EPO) Drugs Market Size Markets, 2021 & 2028
        4.1.2 Epoetin-alfa
        4.1.3 Darbepoetin-alfa
    4.2 By Type - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
        4.2.1 By Type - Global Erythropoietin (EPO) Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Erythropoietin (EPO) Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Erythropoietin (EPO) Drugs Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Homecare
        5.1.4 Specialty Clinics
        5.1.5 Others
    5.2 By Application - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
        5.2.1 By Application - Global Erythropoietin (EPO) Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Erythropoietin (EPO) Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Erythropoietin (EPO) Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
        6.2.1 By Region - Global Erythropoietin (EPO) Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Erythropoietin (EPO) Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Erythropoietin (EPO) Drugs Revenue, 2017-2028
        6.3.2 US Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.3.3 Canada Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.3.4 Mexico Erythropoietin (EPO) Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Erythropoietin (EPO) Drugs Revenue, 2017-2028
        6.4.2 Germany Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.3 France Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.4 U.K. Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.5 Italy Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.6 Russia Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.4.8 Benelux Erythropoietin (EPO) Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Erythropoietin (EPO) Drugs Revenue, 2017-2028
        6.5.2 China Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.5.3 Japan Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.5.4 South Korea Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.5.6 India Erythropoietin (EPO) Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Erythropoietin (EPO) Drugs Revenue, 2017-2028
        6.6.2 Brazil Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.6.3 Argentina Erythropoietin (EPO) Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, 2017-2028
        6.7.2 Turkey Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.7.3 Israel Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Erythropoietin (EPO) Drugs Market Size, 2017-2028
        6.7.5 UAE Erythropoietin (EPO) Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Erythropoietin (EPO) Drugs Major Product Offerings
        7.1.4 Pfizer Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche Erythropoietin (EPO) Drugs Major Product Offerings
        7.2.4 Roche Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.2.5 Roche Key News
    7.3 Amgen
        7.3.1 Amgen Corporate Summary
        7.3.2 Amgen Business Overview
        7.3.3 Amgen Erythropoietin (EPO) Drugs Major Product Offerings
        7.3.4 Amgen Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.3.5 Amgen Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Erythropoietin (EPO) Drugs Major Product Offerings
        7.4.4 Johnson & Johnson Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 Kyowa Kirin
        7.5.1 Kyowa Kirin Corporate Summary
        7.5.2 Kyowa Kirin Business Overview
        7.5.3 Kyowa Kirin Erythropoietin (EPO) Drugs Major Product Offerings
        7.5.4 Kyowa Kirin Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.5.5 Kyowa Kirin Key News
    7.6 Shanghai Dahua Pharmaceutical
        7.6.1 Shanghai Dahua Pharmaceutical Corporate Summary
        7.6.2 Shanghai Dahua Pharmaceutical Business Overview
        7.6.3 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Major Product Offerings
        7.6.4 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.6.5 Shanghai Dahua Pharmaceutical Key News
    7.7 JCR Pharmaceuticals
        7.7.1 JCR Pharmaceuticals Corporate Summary
        7.7.2 JCR Pharmaceuticals Business Overview
        7.7.3 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Major Product Offerings
        7.7.4 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.7.5 JCR Pharmaceuticals Key News
    7.8 Teva Pharmaceuticals
        7.8.1 Teva Pharmaceuticals Corporate Summary
        7.8.2 Teva Pharmaceuticals Business Overview
        7.8.3 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Major Product Offerings
        7.8.4 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue in Global Market (2017-2022)
        7.8.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Erythropoietin (EPO) Drugs Market Opportunities & Trends in Global Market
    Table 2. Erythropoietin (EPO) Drugs Market Drivers in Global Market
    Table 3. Erythropoietin (EPO) Drugs Market Restraints in Global Market
    Table 4. Key Players of Erythropoietin (EPO) Drugs in Global Market
    Table 5. Top Erythropoietin (EPO) Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Erythropoietin (EPO) Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Erythropoietin (EPO) Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Erythropoietin (EPO) Drugs Product Type
    Table 9. List of Global Tier 1 Erythropoietin (EPO) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Erythropoietin (EPO) Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Erythropoietin (EPO) Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Erythropoietin (EPO) Drugs Product Offerings
    Table 32. Pfizer Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Erythropoietin (EPO) Drugs Product Offerings
    Table 35. Roche Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Amgen Corporate Summary
    Table 37. Amgen Erythropoietin (EPO) Drugs Product Offerings
    Table 38. Amgen Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Erythropoietin (EPO) Drugs Product Offerings
    Table 41. Johnson & Johnson Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Kyowa Kirin Corporate Summary
    Table 43. Kyowa Kirin Erythropoietin (EPO) Drugs Product Offerings
    Table 44. Kyowa Kirin Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Shanghai Dahua Pharmaceutical Corporate Summary
    Table 46. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Product Offerings
    Table 47. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. JCR Pharmaceuticals Corporate Summary
    Table 49. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Product Offerings
    Table 50. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Teva Pharmaceuticals Corporate Summary
    Table 52. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Product Offerings
    Table 53. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Erythropoietin (EPO) Drugs Segment by Type in 2021
    Figure 2. Erythropoietin (EPO) Drugs Segment by Application in 2021
    Figure 3. Global Erythropoietin (EPO) Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Erythropoietin (EPO) Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Erythropoietin (EPO) Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2021
    Figure 8. By Type - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 12. US Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 24. China Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Amgen Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Kyowa Kirin Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Erythropoietin Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erythropoietin Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erythropoietin Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ceria Slurries Market

It is ceria-based slurries,which provide excellent defect and low dishing performance. Read More